BUSINESS
BUSINESS
BUSINESS
2024
11 | Awarded the Presidential Citation for Industrial Technology Promotion Merit |
| 10 | Completed Phase 1 clinical trial of organoid-based skin regenerative therapeutic (TRTP-101) |
| 09 | AI+ Certification (AIS-0005-AIPA v1.0) from the Korean Standards Association Completed dosing for Phase 1 clinical trial of organoid-based skin regenerative therapeutic (TRTP-101) |
| 07 | Registered patent for organoid manufacturing method utilizing stem cell self-organization and organoids produced by this method |
06 | INNOBIZ "Technology Innovation-Type SME" Certification |
2023
08 | IND approval for organoid-based skin regenerative therapeutic (TRTP-101), the first in South Korea |
| 05 | Series B Bridge funding (5 billion KRW) |
2022
12 | Awarded the Minister's Award in the "Super Gap Startup" category by the Ministry of SMEs and Startups |
| 03 | Selected as a military service exemption company (for specialized researchers) |
2021
06 | Series B funding (12 billion KRW) |
| 04 | Patent registration for the method of manufacturing decellularized tissues using hydrogel polymers and decellularized tissues produced from this method |
| Expanded and relocated the research institute and office to Munjeong Teratower |
2019
06 | Selected for U-Tech Valley Technology Guarantee by the Technology Guarantee Fund |
| 02 | Series A funding (3.5 billion KRW) |
2018
07 | Patent registration for human umbilical cord-derived mesenchymal stem cells and the method for establishing them. |
2017
12 | Established Corporate Research Institute |
| 08 | Selected as an Excellent R&D Company by the Small and Medium Business Administration |
2016
11 | Venture company certification Patent registration for structural scaffolds for tissue regeneration and the method for manufacturing them. |
2015
06 | (DBS Co., Ltd.) Animal Stem Cell Development Agreement |
2014
12 | Establishment of CELLinCELLS Co., Ltd. |
2024
| 2024.11 | Awarded the Presidential Citation for Industrial Technology Promotion Merit |
| 2024.10 | Completed Phase 1 clinical trial of organoid-based skin regenerative therapeutic (TRTP-101) |
| 2024.09 | AI+ Certification (AIS-0005-AIPA v1.0) from the Korean Standards Association |
| Completed dosing for Phase 1 clinical trial of organoid-based skin regenerative therapeutic (TRTP-101) | |
| 2024.07 | Registered patent for organoid manufacturing method utilizing stem cell self-organization and organoids produced by this method |
| 2024.06 | INNOBIZ "Technology Innovation-Type SME" Certification |
2023
| 2023.08 | IND approval for organoid-based skin regenerative therapeutic (TRTP-101), the first in South Korea |
| 2023.05 | Series B Bridge funding (5 billion KRW) |
2022
| 2022.12 | Awarded the Minister's Award in the "Super Gap Startup" category by the Ministry of SMEs and Startups |
| Selected as a military service exemption company (for specialized researchers) | |
| 2022.03 | Expanded and relocated the research institute and office to Munjeong Teratower |
2021
| 2021.06 | Series B funding (12 billion KRW) |
| 2021.04 | Patent registration for the method of manufacturing decellularized tissues using hydrogel polymers and decellularized tissues produced from this method |
| Expanded and relocated the research institute and office to Munjeong Teratower |
2019
| 2019.06 | Selected for U-Tech Valley Technology Guarantee by the Technology Guarantee Fund |
| 2019.02 | Series A funding (3.5 billion KRW) |
2018
| 2018.07 | Patent registration for human umbilical cord-derived mesenchymal stem cells and the method for establishing them. |
2017
| 2017.12 | Established Corporate Research Institute |
| 2017.08 | Selected as an Excellent R&D Company by the Small and Medium Business Administration |
2016
| 2016.11 | Venture company certification Patent registration for structural scaffolds for tissue regeneration and the method for manufacturing them. |
2015
| 2015.06 | (DBS Co., Ltd.) Animal Stem Cell Development Agreement |
2014
| 2014.12 | Establishment of CELLinCELLS Co., Ltd. |
2nd Floor, Room 203, 240-39 Changgyeonggung-ro, Jongno-gu, Seoul, South Korea (Gwangwon Building, Myeongnyun 4-ga)
TEL +82-2-742-0032 FAX +82-2-764-7300
Room 501, Biomaterials Research Building, 101 Daehak-ro, Jongno-gu, Seoul, South Korea (Seoul National University School of Dentistry)
TEL +82-2-740-8641 FAX +82-2-742-8666
Room 523, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
TEL +82-2-742-0032 FAX +82-2-764-7300
Rooms 513–515, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
TEL +82-2-742-0032 FAX +82-2-764-7300
2nd Floor, Room 203, 240-39 Changgyeonggung-ro, Jongno-gu, Seoul, South Korea (Gwangwon Building, Myeongnyun 4-ga)
TEL +82-2-742-0032
FAX +82-2-764-7300
Room 501, Biomaterials Research Building, 101 Daehak-ro, Jongno-gu, Seoul, South Korea
(Seoul National University School of Dentistry)
TEL +82-2-740-8641
FAX +82-2-742-8666
Room 523, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea
(Teratower, Munjeong Station)
TEL +82-2-742-0032
FAX +82-2-764-7300
Rooms 513–515, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea
(Teratower, Munjeong Station)
TEL +82-2-742-0032
FAX +82-2-764-7300
office@cellincells.com
Copyrights © 2025 CELLinCELLS co.,Ltd. All Rights Reserved.